Kura Oncology, Inc. (KURA) total debt

Total debt · fiscal 2025
$20.46M

Kura Oncology, Inc. (KURA) carried total debt of $20.46M at the end of fiscal 2025 (December 31, 2025). That is 23.3% higher than the $16.59M of fiscal 2024. Figures as of 18 Nov 2026, 11:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$20.46M
Change on fiscal 2024
+23.3%
Growth, 5 years
+23.1% a year
Highest on record
$20.46Mfiscal 2025
Lowest on record
$7.10Mfiscal 2017
Fiscal years on record
92016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Kura Oncology, Inc. total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 23.1% a year. Across the 9 fiscal years on record (2016–2025), the highest was $20.46M in fiscal 2025 and the lowest $7.10M in fiscal 2017.

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

History · 9 fiscal years

Total debt by fiscal year

Kura Oncology, Inc. total debt, year by year

Kura Oncology, Inc. (KURA) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$20.46M 23.3% up0.1×
2024$16.59M 3.5% down0.0×
2023$17.20M 22.6% up0.0×
2022$14.02M—0.0×
2020$7.25M 3.3% down0.0×
2019$7.50M 0.0%0.0×
2018$7.50M 5.7% up0.0×
2017$7.10M 3.1% down0.1×
2016$7.32M—0.1×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on KURA

Kura Oncology, Inc., figure by figure

Kura Oncology, Inc. (KURA) overview: price, valuation and scorecard

Kura Oncology, Inc. total debt: questions and answers

How much debt does Kura Oncology, Inc. have?

Kura Oncology, Inc. (KURA) carried total debt of $20.46M at the end of fiscal 2025 (December 31, 2025). That is 23.3% higher than the $16.59M of fiscal 2024.

What is the growth rate of Kura Oncology, Inc.'s total debt?

Over the five fiscal years to 2025 total debt grew at a compound 23.1% a year.

What are the highest and lowest total debt figures on record for Kura Oncology, Inc.?

Across the 9 fiscal years on record (2016–2025), the highest was $20.46M in fiscal 2025 and the lowest $7.10M in fiscal 2017.

How does Kura Oncology, Inc.'s debt compare with its equity?

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

How is Kura Oncology, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Kura Oncology, Inc. it is on record here for 9 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kura Oncology, Inc. (KURA) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/KURA/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.